Dominant drug targets suppress the emergence of antiviral resistance

作者: Elizabeth J Tanner , Hong-mei Liu , M Steven Oberste , Mark Pallansch , Marc S Collett

DOI: 10.7554/ELIFE.03830

关键词:

摘要: The emergence of drug resistance can defeat the successful treatment of pathogens that display high mutation rates, as exemplified by RNA viruses. Here we detail a new paradigm in which a single compound directed against a ‘dominant drug target’ suppresses the emergence of naturally occurring drug-resistant variants in mice and cultured cells. All new drug-resistant viruses arise during intracellular replication and initially express their phenotypes in the presence of drug-susceptible genomes. For the targets of most anti-viral compounds, the presence of these drug-susceptible viral genomes does not prevent the selection of drug resistance. Here we show that, for an inhibitor of the function of oligomeric capsid proteins of poliovirus, the expression of drug-susceptible genomes causes chimeric oligomers to form, thus rendering the drug-susceptible genomes dominant. The use of dominant drug targets should suppress drug resistance whenever multiple genomes arise in the same cell and express products in a common milieu.

参考文章(31)
J J Holland, J C de la Torre, D A Steinhauer, D Clarke, E Duarte, E Domingo, Virus mutation frequencies can be greatly underestimated by monoclonal antibody neutralization of virions. Journal of Virology. ,vol. 63, pp. 5030- 5036 ,(1989) , 10.1128/JVI.63.12.5030-5036.1989
Luke W. Meredith, Haran Sivakumaran, Lee Major, Andreas Suhrbier, David Harrich, Potent Inhibition of HIV-1 Replication by a Tat Mutant PLoS ONE. ,vol. 4, pp. e7769- 11 ,(2009) , 10.1371/JOURNAL.PONE.0007769
Diana V Kouiavskaia, Eugenia M Dragunsky, Hong-Mei Liu, M Steven Oberste, Marc S Collett, Konstantin M Chumakov, Immunological and pathogenic properties of poliovirus variants selected for resistance to antiviral drug V-073. Antiviral Therapy. ,vol. 16, pp. 999- 1004 ,(2011) , 10.3851/IMP1838
Scott Crowder, Karla Kirkegaard, Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses Nature Genetics. ,vol. 37, pp. 701- 709 ,(2005) , 10.1038/NG1583
G. D. Diana, M. A. McKinlay, M. J. Otto, V. Akullian, C. Oglesby, [[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating. Journal of Medicinal Chemistry. ,vol. 28, pp. 1906- 1910 ,(1985) , 10.1021/JM00150A025
Armando M. De Palma, Gerhard Pürstinger, Eva Wimmer, Amy K. Patick, Koen Andries, Bart Rombaut, Erik De Clercq, Johan Neyts, Potential use of antiviral agents in polio eradication. Emerging Infectious Diseases. ,vol. 14, pp. 545- 551 ,(2008) , 10.3201/EID1404.070439
Hong-Mei Liu, Jason A. Roberts, Deborah Moore, Barbara Anderson, Mark A. Pallansch, Daniel C. Pevear, Marc S. Collett, M. Steven Oberste, Characterization of Poliovirus Variants Selected for Resistance to the Antiviral Compound V-073 Antimicrobial Agents and Chemotherapy. ,vol. 56, pp. 5568- 5574 ,(2012) , 10.1128/AAC.00539-12